← Back to all trials
Completed
NCT07871045
Vascular Resection in Robotic Pancreaticoduodenectomy for Pancreatic Cancer
Conditions: Vascular Resection, Pancreatic Cancer, Robotic Pancreaticoduodenectomy
Sex: All
Healthy volunteers: No
Enrollment: 239
Sponsor: Taipei Veterans General Hospital, Taiwan
Location: General Surgery, Taipei Veterans General Hospital Taipei Other
Summary
Data for this propensity score-matched (PSM) comparative study were obtained from a prospectively maintained database comprising 679 cases of robotic pancreaticoduodenectomy (RPD). This study aimed to evaluate the feasibility and justification of vascular resection (VR) in RPD for pancreatic cancer. The primary study endpoint was to compare the surgical outcomes between patients undergoing VR (+) and VR (-) in RPD using PSM to minimize selection bias and allow for balanced comparisons. The secondary study endpoint was to assess the impact of VR on oncological outcomes and overall survival in patients with pancreatic cancer undergoing RPD.
Eligibility Criteria
Inclusion Criteria:
\- Pancreatic cancer undergoing robotic pancreaticoduodenectomy
Exclusion Criteria:
* severe intra-abdominal adhesions
* extensive vascular encasement exceeding 2 cm
Source: ClinicalTrials.gov (NCT07871045). StuddyBuddy aggregates publicly available trial information.